New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.
EU funds first study of psychedelics for terminally ill patients bnn-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnn-news.com Daily Mail and Mail on Sunday newspapers.
A European consortium of 19 partners has been awarded over €6.5M by the European Union to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.